Mibavademab
- Generic Name
- Mibavademab
- Drug Type
- Biotech
- CAS Number
- 2305770-44-7
- Unique Ingredient Identifier
- PHL2UDY3AB
- Background
Mibavademab is under investigation in clinical trial NCT04159415 (Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath